Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

TGR Foundation
Tiger Woods’ TGR Foundation Is Reimagining Educational Access Through STEAM, AI, and Community Partnerships
May 19, 2026

As schools across the United States continue grappling with post-pandemic learning loss, declining student engagement, and shrinking emergency funding, nonprofit organizations are increasingly stepping in to fill critical gaps. Recent national studies on literacy recovery, student engagement, and career-connected learning show that educators are facing significant post-pandemic challenges in keeping students connected to pathways that…

Read More
Talent
Higher Ed Must Build a Talent Supply Chain to Fix Workforce Readiness
May 18, 2026

The traditional pathway from college to career is starting to break down—and both universities and employers are feeling the strain. Higher education is under mounting pressure to prove career outcomes as employers question graduate readiness and internships decline. In fact, many institutions are reporting shrinking internship pipelines even as employers continue to prioritize prior…

Read More
healthcare
The Healthcare Talent Fix: Build Pipelines Early, Use Data, and Get the Experience Right
May 18, 2026

There’s a growing tension inside healthcare right now—between the people leaving the workforce and the patients still arriving every day. It’s a dynamic that leaders can no longer afford to ignore. The numbers make that clear: the Association of American Medical Colleges estimates that the U.S. could be short of as many as 86,000 physicians…

Read More
education
Just Thinking… About Federal Funds, Student Support, and the Future of Education with Eric Reaves
May 15, 2026

As conversations around the future of the U.S. Department of Education continue to intensify, educators and federal program leaders are facing mounting uncertainty about how federal funds will be managed, distributed, and regulated. At the same time, schools serving historically underserved students remain heavily reliant on programs like Title I and other federally supported initiatives…

Read More